Datexim Overview

  • Founded
  • 2009

Founded
  • Status
  • Private

  • Employees
  • 18

Employees
  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $1.18M

  • Investors
  • 4

Datexim General Information

Description

Developer of digital pathology application and technology intended for imaging-based digital pathology and telemedicine. The company's application facilitate automatic screening for detection of cervical cancer and review of histopathology images over the web, enabling the healthcare community and pathology laboratories to raise diagnostic accuracy.

Contact Information

Website
www.datexim.ai
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Decision/Risk Analysis
Business/Productivity Software
Enterprise Systems (Healthcare)
Primary Office
  • 24-26 rue Saint Martin
  • 14000 Caen
  • France
+33 02 00 00 00 00

Datexim Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Datexim Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 12-Oct-2020 $1.18M 00.000 00.000 Completed Generating Revenue
4. Later Stage VC 05-Apr-2019 00.000 00.000 00.000 Completed Generating Revenue
3. Seed Round 08-Mar-2017 00000 000000 00.000 Completed Generating Revenue
2. Angel (individual) 18-May-2015 $418K $418K 00.000 Completed Startup
1. Accelerator/Incubator 01-May-2009 Completed Startup
To view Datexim’s complete valuation and funding history, request access »

Datexim Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 00,000 00.000000 000.00 000.00 00 000.00 0.000
ADP2019 000,000 00.000000 000.00 000.00 00 000.00 00.000
Ordinary 15,316 $1.127951 $40.46 $40.46 1x $40.46 6.65%
Ordinary 12,528 $1.127951 $33.84 $33.84 1x $33.84 5.44%
To view Datexim’s complete cap table history, request access »

Datexim Patents

Datexim Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-3048524-A1 Remote display system of medical image Withdrawn 07-Mar-2016 0000000000 0

Datexim Executive Team (6)

Name Title Board Seat Contact Info
Arnaud Renouf Ph.D Co-Founder, Chief Executive Officer & President
Vianney Thurotte Chief Technology Officer
David Lelouvier Advisor
Laurent Henault Chief Operating Officer
You’re viewing 4 of 6 executive team members. Get the full list »

Datexim Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Datexim Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Odyssee Venture Venture Capital Minority 000 0000 000000 0
Normandie Business Angels Angel Group Minority 000 0000 000000 0
Normandie Participations Venture Capital Minority 000 0000 000000 0
Normandie Incubation Accelerator/Incubator Minority 000 0000 000000 0
To view Datexim’s complete investors history, request access »